Normal male sexual differentiation and aetiology of disorders of sex development

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 25, Issue 2, 2011, Pages 221-238

  Rey, Rodolfo A ^a,b   Grinspon, Romina P ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Androgen Insensitivity Syndrome; Androgens; Anti M llerian hormone; Gonadal Dysgenesis; Hypogonadism; Insulin like factor 3; Leydig cell; Persistent M llerian Duct Syndrome; Sertoli cell; Sex Differentiation Disorders; Sexual Development; Steroid synthesis defects; Urogenital abnormalities

Indexed keywords

ANDROGEN; CALCITONIN GENE RELATED PEPTIDE; INSULIN LIKE FACTOR 3; MUELLERIAN INHIBITING FACTOR; PEPTIDE HORMONE; TESTIS PEPTIDE HORMONE; TRANSCRIPTION FACTOR HOXA10; UNCLASSIFIED DRUG;

ANDROGEN DEFICIENCY; ANDROGEN INSENSITIVITY SYNDROME; DIHYDROTESTOSTERONE DEFICIENCY; EARLY DIAGNOSIS; EMBRYO DEVELOPMENT; FETUS DEVELOPMENT; FETUS DISEASE; GENE MUTATION; GENITAL SYSTEM; GONAD DEVELOPMENT; GONADUCT; HORMONE ACTION; HORMONE DEFICIENCY; HUMAN; HYPOGONADISM; LEYDIG CELL; LEYDIG CELL SPECIFIC DYSFUNCTION; MORPHOGENESIS; MUELLERIAN DUCT; MUELLERIAN INHIBITING FACTOR DEFICIENCY; MUELLERIAN INHIBITING FACTOR INSENSITIVITY; MULTIPLE ORGAN FAILURE; OVARY; PATHOGENESIS; REVIEW; SERTOLI CELL; SERTOLI CELL SPECIFIC DYSFUNCTION; SEX DIFFERENTIATION; SEX DIFFERENTIATION DISORDER; SEXUAL DEVELOPMENT; STEROIDOGENESIS; TESTIS; TESTIS FUNCTION; UROGENITAL SINUS; VIRILIZATION; Y CHROMOSOME;

ANDROGEN-INSENSITIVITY SYNDROME; ANIMALS; ANTI-MULLERIAN HORMONE; DISORDERS OF SEX DEVELOPMENT; FEMALE; GONADS; HUMANS; HYPOGONADISM; INSULIN; MALE; PROTEINS; SEX DIFFERENTIATION; SEXUAL DEVELOPMENT; TESTOSTERONE;

EID: 79952559094     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2010.08.013     Document Type: Review

References (68)

1. Hughes IA, Houk C, Ahmed SF et al. Consensus statement on management of intersex disorders. Archives of Disease in Childhood 2006; 91: 554-563. (Pubitemid 44023350)
2. Jost A. Problems of fetal endocrinology: the gonadal and hypophyseal hormones. Recent Progress in Hormone Research 1953; 8: 379-418.
3. Wylie C. Germ cells. Current Opinion In Genetics and Development 2000; 10: 410-413. (Pubitemid 30450045)
4. Sekido R & Lovell-Badge R. Sex determination and SRY: down to a wink and a nudge? Trends in Genetics 2009; 25: 19-29.
5. Rey RA & Josso N. Sexual differentiation. In De Groot LJ (ed.). Endotext.org. S. Datmouth, MA, USA: MDTEXT.com, 2009. pp Cited 2010 Jan 26-Available from: http://www.endotext.org/pediatrics/pediatrics7/ pediatricsframe7.htm.
6. Jordan BK, Mohammed M, Ching ST et al. Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans. American Journal of Human Genetics 2001; 68: 1102-1109. (Pubitemid 32424409)
7. Kim Y, Kobayashi A, Sekido R et al. Fgf9 and Wnt4 act as antagonistic signals to regulate mammalian sex determination. PLoS Biology 2006; 4: e187.
8. Yao HH, Matzuk MM, Jorgez CJ et al. Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Developmental Dynamics 2004; 230: 210-215. (Pubitemid 38669583)
9. Rey R, Lukas-Croisier C, Lasala C & Bedecarrás P. AMH/MIS: what we know already about the gene, the protein and its regulation. Molecular and Cellular Endocrinology 2003; 211: 21-31. (Pubitemid 37491231)
10. Rey RA, Musse M, Venara M & Chemes HE. Ontogeny of the androgen receptor expression in the fetal and postnatal testis: its relevance on Sertoli cell maturation and the onset of adult spermatogenesis. Microscopy Research and Technique 2009; 72: 787-795.
11. Josso N, Belville C, di Clemente N & Picard JY. AMH and AMH receptor defects in persistent Mullerian duct syndrome. Human Reproduction Update 2005; 11: 351-356. (Pubitemid 40895464)
12. Taguchi O, Cunha GR, Lawrence WD & Robboy SJ. Timing and irreversibility of Müllerian duct inhibition in the embryonic reproductive tract of the human male. Developmental Biology 1984; 106: 394-398. (Pubitemid 15156772)
13. Parker KL, Rice DA, Lala DS et al. Steroidogenic factor 1: an essential mediator of endocrine development. Recent Progress in Hormone Research 2002; 57: 19-36.
14. Svechnikov K, Landreh L, Weisser J et al. Origin, development and regulation of human Leydig cells. Hormone Research in Paediatrics 2010; 73: 93-101.
15. Biason-Lauber A. Control of sex development. Best Practice & Research Clinical Endocrinology & Metabolism 2010; 24: 163-186.
16. Thliveris JA & Currie RW. Observations on the hypothalamo-hypophyseal portal vasculature in the developing human fetus. American Journal of Anatomy 1980; 157: 441-444. (Pubitemid 10086124)
17. Hannema SE & Hughes IA. Regulation of Wolffian duct development. Hormone Research 2007; 67: 142-151. (Pubitemid 46355588)
18. Winter JS, Faiman C & Reyes FI. Sex steroid production by the human fetus: its role in morphogenesis and control by gonadotropins. Birth Defects Original Article Series 1977; 13: 41-58. (Pubitemid 8120048)
19. O'Shaughnessy PJ, Baker PJ, Monteiro A et al. Developmental changes in human fetal testicular cell numbers and messenger ribonucleic acid levels during the second trimester. Journal of Clinical Endocrinology and Metabolism 2007; 92: 4792-4801. (Pubitemid 350223462)
20. Tapanainen J, Kellokumpu-Lehtinen P, Pelliniemi LJ & Huhtanemi I. Age-related changes in endogenous steroids of human fetal testis during early and midpregnancy. Journal of Clinical Endocrinology Metabolism 1981; 52: 98-102. (Pubitemid 11217848)
21. Brioude F, Bouligand J, Trabado S et al. Non-syndromic congenital hypogonadotropic hypogonadism: clinical presentation and genotype-phenotype relationships. European Journal of Endocrinology 2010; 162: 835-851.
22. Feng S, Ferlin A, Truong A et al. INSL3/RXFP2 signaling in testicular descent. Annals of the New York Academy of Sciences 2009; 1160(197-204): 197-204.
23. Feldman KW & Smith DW. Fetal phallic growth and penile standards for newborn male infants. Journal of Pediatrics 1975; 86: 395-398.
24. Zalel Y, Pinhas-Hamiel O, Lipitz S et al. The development of the fetal penis - an in utero sonographic evaluation. Ultrasound in Obstetrics and Gynecology 2001; 17: 129-131.
25. Kaplan GW & Lamm DL. Embryogenesis of chordee. Journal of Urology 1975; 114: 769-772.
26. Nation TR, Balic A, Southwell BR et al. The hormonal control of testicular descent. Pediatric Endocrinology Review 2009; 7: 22-31.
27. Ivell R & Anand-Ivell R. Biology of insulin-like factor 3 in human reproduction. Human Reproduction Update 2009; 15: 463-476.
28. Belville C, Marechal JD, Pennetier S et al. Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport. Human Molecular Genetics 2009; 18: 3002-3013.
29. Werner R, Grötsch H & Hiort O. 46, XY disorders of sex development - the undermasculinised male with disorders of androgen action. Best Practice & Research Clinical Endocrinology & Metabolism 2010; 24: 263-277.
30. Ferlin A, Zuccarello D, Zuccarello B et al. Genetic alterations associated with cryptorchidism. Journal of the American Medical Association 2008; 300: 2271-2276.
31. Nuti F, Marinari E, Erdei E et al. The leucine-rich repeat-containing G protein-coupled receptor 8 gene T222P mutation does not cause cryptorchidism. Journal of Clinical Endocrinology and Metabolism 2008; 93: 1072-1076. (Pubitemid 351398594)
32. Chillon M, Casals T, Mercier B et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. New England Journal of Medicine 1995; 332: 1475-1480.
33. Rey RA, Codner E, Iñíguez G et al. Low risk of impaired testicular Sertoli and Leydig cell functions in boys with isolated hypospadias. Journal of Clinical Endocrinology and Metabolism 2005; 90: 6035-6040. (Pubitemid 41606522)
34. Warne S, Chitty LS & Wilcox DT. Prenatal diagnosis of cloacal anomalies. BJU International 2002; 89: 78-81. (Pubitemid 34117769)
35. Grinspon RP & Rey RA. Anti-mullerian hormone and sertoli cell function in paediatric male hypogonadism. Hormone Research in Paediatrics 2010; 73: 81-92.
36. Rey RA, Belville C, Nihoul-Fékété C et al. Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement. Journal of Clinical Endocrinology and Metabolism 1999; 84: 627-631. (Pubitemid 29075696)
37. Kubini K, Zachmann M, Albers N et al. Basal inhibin B and the testosterone response to human chorionic gonadotropin correlate in prepubertal boys. Journal of Clinical Endocrinology and Metabolism 2000; 85: 134-138. (Pubitemid 32268802)
38. Arcari AJ, Bergadá I, Rey RA & Gottlieb S. Predictive value of anatomical findings and karyotype analysis in the diagnosis of patients with disorders of sexual development. Sexual Development 2007; 1: 222-229. (Pubitemid 47236992)
39. Kohler B, Lin L, Mazen I et al. The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46, XY males without adrenal insufficiency. European Journal of Endocrinology 2009; 161: 237-242.
40. Steinmetz L, Rocha MN, Longui CA et al. Inhibin A production after gonadotropin stimulus: a new method to detect ovarian tissue in ovotesticular disorder of sex development. Hormone Research 2009; 71: 94-99.
41. Veitia R, Ion A, Barbaux S et al. Mutations and sequence variants in the testis-determining region of the Y chromosome in individuals with a 46, XY female phenotype. Human Genetics 1997; 99: 648-652. (Pubitemid 27192598)
42. Fukami M, Wada Y, Miyabayashi K et al. CXorf6 is a causative gene for hypospadias. Nature Genetics 2006; 38: 1369-1371. (Pubitemid 44837556)
43. Bardoni B, Zanaria E, Guioli S et al. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nature Genetics 1994; 7: 497-501. (Pubitemid 24308336)
44. Fallat ME & Donahoe PK. Intersex genetic anomalies with malignant potential. Current Opinion in Pediatrics 2006; 18: 305-311. (Pubitemid 43832709)
45. Ottolenghi C & McElreavey K. Deletions of 9p and the quest for a conserved mechanism of sex determination. Molecular Genetics and Metabolism 2000; 71: 397-404.
46. Haldin CE & LaBonne C. SoxE factors as multifunctional neural crest regulatory factors. The International Journal of Biochemistry & Cell Biology 2010; 42: 441-444.
47. Umehara F, Tate G, Itoh K et al. A novel mutation of desert hedgehog in a patient with 46, XY partial gonadal dysgenesis accompanied by minifascicular neuropathy. American Journal of Human Genetics 2000; 67: 1302-1305.
48. Canto P, Söderlund D, Reyes E & Méndez JP. Mutations in the desert hedgehog (DHH) gene in patients with 46, XY complete pure gonadal dysgenesis. Journal of Clinical Endocrinology and Metabolism 2004; 89: 4480-4483. (Pubitemid 39244458)
49. Reardon W, Gibbons RJ, Winter RM & Baraitser M. Male pseudohermaphroditism in sibs with the alpha-thalassemia/mental retardation (ATR-X) syndrome. American Journal of Medical Genetics 1995; 55: 285-287.
50. Porter FD. Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management. European Journal of Human Genetics 2008; 16: 535-541. (Pubitemid 351594119)
51. Puffenberger EG, Hu-Lince D, Parod JM et al. Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of function. Proceedings of the National Academy of Sciences of the United States of America 2004; 101: 11689-11694. (Pubitemid 39095357)
52. Main KM, Skakkebmk NE, Virtanen HE & Toppari J. Genital anomalies in boys and the environment. Best Practice & Research Clinical Endocrinology & Metabolism 2010; 24: 279-289.
53. Mendonça BB, Costa EMF, Belgorosky A et al. 46, XY DSD due to impaired androgen production. Best Practice & Research Clinical Endocrinology & Metabolism 2010; 24: 243-262.
54. Latronico AC, Anasti J, Arnhold IJ et al. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. New England Journal of Medicine 1996; 334: 507-512. (Pubitemid 26067739)
55. Miller WL. Disorders of androgen synthesis - from cholesterol to dehydroepiandrosterone. Medical Principles and Practice 2005; 1(14 Suppl): 58-68. (Pubitemid 41161050)
56. Gupta MK, Geller DH & Auchus RJ. Pitfalls in characterizing P450c17 mutations associated with isolated 17,20-Lyase deficiency. Journal of Clinical Endocrinology and Metabolism 2001; 86: 4416-4423. (Pubitemid 32848568)
57. Lee YS, Kirk JM, Stanhope RG et al. Phenotypic variability in 17beta-hydroxysteroid dehydrogenase-3 deficiency and diagnostic pitfalls. Clinical Endocrinology 2007; 67: 20-28. (Pubitemid 46955434)
58. Miller WL, Huang N, Agrawal V & Giacomini KM. Genetic variation in human P450 oxidoreductase. Molecular and Cellular Endocrinology 2009; 300: 180-184.
59. Giordano SJ, Kaftory A & Steggles AW. A splicing mutation in the cytochrome b5 gene from a patient with congenital methemoglobinemia and pseudohermaphrodism. Human Genetics 1994; 93: 568-570. (Pubitemid 24125581)
60. Thompson ST, Grillis MA, Wolkoff LH & Katzin WE. Transverse testicular ectopia in a man with persistent Müllerian duct syndrome. Archives of Pathology and Laboratory Medicine 1994; 118: 752-755. (Pubitemid 24217611)
61. Huhtaniemi IT. The role of mutations affecting gonadotrophin secretion and action in disorders of pubertal development. Best Practice & Research Clinical Endocrinology & Metabolism 2002; 16: 123-138.
62. Imperato-McGinley J & Zhu YS. Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency. Molecular and Cellular Endocrinology 2002; 198: 51-59. (Pubitemid 36169934)
63. Rey R, Mebarki F, Forest MG et al. Anti-müllerian hormone in children with androgen insensitivity. Journal of Clinical Endocrinology and Metabolism 1994; 79: 960-964.
64. Ahmed SF & Rodie M. Investigation and initial management of ambiguous genitalia. Best Practice & Research Clinical Endocrinology & Metabolism 2010; 24: 197-218.
65. Brain CE, Creighton SM, Mushtaq I et al. Holistic management of DSD. Best Practice & Research Clinical Endocrinology & Metabolism 2010; 24: 335-354.
66. Thyen U, Lanz K, Holterhus PM & Hiort O. Epidemiology and initial management of ambiguous genitalia at birth in Germany. Hormone Research 2006; 66: 195-203. (Pubitemid 44413281)
67. Hurme T, Lahdes-Vasama T, Makela E et al. Clinical findings in prepubertal girls with inguinal hernia with special reference to the diagnosis of androgen insensitivity syndrome. Scandinavian Journal of Urology and Nephrology 2009; 43: 42-46.
68. Adachi M, Takayanagi R, Tomura A et al. Androgen-insensitivity syndrome as a possible co-activator disease. New England Journal of Medicine 2000; 343: 856-862.